Telehealth Behavioral Activation for Teens

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorBaylor College of Medicine

About this trial

Behavioral activation is one such empirically supported intervention. Derived from cognitive-behavioral therapy, a well-established treatment for depression, behavioral activation uses psychoeducation and skill-building to increase an individual's engagement in valued and enjoyable activities (e.g., socializing with family and friends, exercising, participating in a hobby) in order to improve depressive symptoms. Research has shown that behavioral activation is an effective intervention for depressed youth. Additionally, it has been shown as a promising intervention that can be conducted in a brief, virtual format and can be effectively implemented by both trained clinicians and trained, non-licensed interventionists. This project will provide Behavioral Activation for youth (12-17) experiencing depression or suicidal ideation who are currently enrolled in the Youth Depression Suicide Network study in Texas.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants must be enrolled in the Texas Youth Depression Suicide Research Network (TX-YDSRN) Registry Study;

Be between the ages of 12- 18 or currently enrolled in high school;

Have a caregiver that is willing to participate in the program;

Be able to commit to weekly sessions for eight weeks;

Disqualifiers

Have an acute medical or psychological condition(s) that that would, in the judgment of the study medical clinician, make participation difficult or unsafe;

Have an acute medical or psychological condition(s) that would result in an inability to accurately complete study requirements (e.g., neurological conditions or significant neurodevelopmental concerns);

Have active psychotic or manic symptoms resulting in altered mental status and inability to provide assent or requiring immediate attention and/or higher level of intervention;

Have a parent/LAR/guardian who is deemed cognitively unable to provide consent (if youth participant, aged 12-17).

Trial design

Design model

Single group

Treatments tested in this trial

  • Behavioral Activation

    Other intervention

    All participants will undergo behavioral activation treatment for 8-10 weeks

Treatment groups

250 Participants
are divided into 1 treatment group
Group A: Behavioral Activation (BA)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Patient Health Questionnaire 9-modified for adolescents (PHQ-A)

Depression; 4-point Likert scale (0= Not at all; 3= Nearly every day), Score range 0-27 (higher scores indicate greater depression severity)

Time frame
During treatment (every session (week) 1-10)
2

Behavioral Activation for Depression-Short Form (BAD-SF)

Behavioral Activation; 6-point Likert scale (0= Not al all; 6= Completely), Score range 0-54 (higher scores indicate higher activation)

Time frame
During treatment (every session (week) 1-10)
3

Dimensional Anhedonia Rating Scale (DARS)

Anhedonia; 5-point Likert scale (0= Not at all; 4= Very much), Score range 0- 68 (higher scores indicate less anhedonia)

Time frame
Baseline (before treatment), post-treatment (session/week 11)

Secondary outcomes

1

Strengths and Difficulties Questionnaire (SDQ)

Behavioral screening; 3-point Likert scale (0= Not at all; 2= Certainly True), Score range 0-40 (higher scores indicate more difficulties)

Time frame
Baseline (before treatment), post-treatment (session/week 11)
2

Duke Social Support Index (DSSI)

Social Support; Multiple Likert scales ((1 = None; 3= More than 2 people)(1= Hardly ever; 3= Most of the time)), Score range 10 -20 (higher scores indicate a higher level of social support)

Time frame
Baseline (before treatment), post-treatment (session/week 11)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Baylor College of Medicine

Lead sponsor

University of Texas

Collaborator